Clinical trial
IMX-110 in Patients With Advanced Solid Tumors
NCT03382340
Study timeline
Study start (actual)2018-02-15Date precision: day
Registry last updated2023-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumor, Adultunresolved
Advanced Solid Tumorsunresolved
Pancreatic Cancerunresolved
Breast Cancerunresolved
Ovarian Cancerunresolved
Interventions
Imx-110DRUG
Sponsors & collaborators
Immix Biopharma Australia Pty Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03382340 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.